RENOCRIT 2000 IU INJECTION

Renocrit 2000IU injection combines active components like Epoetin and recombinant human erythropoietin. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The medication is used to treat anemia that is due to chronic kidney diseases (CKD), chemotherapy for cancer, or HIV treatment using zidovudine. It also decreases the need for transfusions of red blood cells for patients at risk of losing blood because of planned surgery and other surgical procedures.
Renocrit 2000IU injections should not be used by patients who have sensitization to its component or, one of them, uncontrolled hypertension, active thrombotic microangiopathy (TMA) and Pure red cell cancer (PRCA) seizures that are not controlled and pregnancy or lactation. It is also recommended to use it carefully in patients with bleeding clots, heart disease, kidney disease, stroke, liver diseases, thalassemia, sickle cell anemia(SCA), myelodysplastic disorder, cancer, or leukemia. It is not recommended for use in children under 18 in cases where the benefits are greater than the risks. Seniors using this medication should be watched closely for adverse consequences. Before you begin this treatment, you must speak with your doctor about the risks and advantages associated with Renocrit 200IU.